Welcome to your Daily Dose of Health Tech Innovation!Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.We bring you expert-curated insights,
SkylineDx announced that an independent meta-analysis has confirmed the performance of its Merlin CP-GEP assay in correctly stratifying melanoma patients for sentinel lymph node biopsy
Sentinel lymph node (SLN) status alone is not sufficient as node negative patients still experience relapse and melanoma-related death. SkylineDx, an innovative diagnostics company specializing in
Fuel up with free Health Tech Insights
